201 related articles for article (PubMed ID: 23180681)
41. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.
Ahn J; Albanes D; Berndt SI; Peters U; Chatterjee N; Freedman ND; Abnet CC; Huang WY; Kibel AS; Crawford ED; Weinstein SJ; Chanock SJ; Schatzkin A; Hayes RB;
Carcinogenesis; 2009 May; 30(5):769-76. PubMed ID: 19255064
[TBL] [Abstract][Full Text] [Related]
42. Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival.
Weinstein SJ; Mondul AM; Yu K; Layne TM; Abnet CC; Freedman ND; Stolzenberg-Solomon RZ; Lim U; Gail MH; Albanes D
Eur J Epidemiol; 2018 Nov; 33(11):1087-1099. PubMed ID: 30073448
[TBL] [Abstract][Full Text] [Related]
43. Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade.
Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
Cancer Causes Control; 2012 Nov; 23(11):1865-73. PubMed ID: 22926301
[TBL] [Abstract][Full Text] [Related]
44. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D.
Sollid ST; Hutchinson MY; Berg V; Fuskevåg OM; Figenschau Y; Thorsby PM; Jorde R
Eur J Endocrinol; 2016 Apr; 174(4):445-52. PubMed ID: 26733479
[TBL] [Abstract][Full Text] [Related]
45. Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study.
Weinstein SJ; Peters U; Ahn J; Friesen MD; Riboli E; Hayes RB; Albanes D
PLoS One; 2012; 7(7):e40204. PubMed ID: 22792240
[TBL] [Abstract][Full Text] [Related]
46. Longitudinal changes in serum vitamin D binding protein and free 25-hydroxyvitamin D in a multiracial cohort of pregnant adolescents.
Best CM; Pressman EK; Queenan RA; Cooper E; O'Brien KO
J Steroid Biochem Mol Biol; 2019 Feb; 186():79-88. PubMed ID: 30278215
[TBL] [Abstract][Full Text] [Related]
47. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.
Stolzenberg-Solomon RZ; Vieth R; Azad A; Pietinen P; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2006 Oct; 66(20):10213-9. PubMed ID: 17047087
[TBL] [Abstract][Full Text] [Related]
48. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.
Stolzenberg-Solomon RZ; Hayes RB; Horst RL; Anderson KE; Hollis BW; Silverman DT
Cancer Res; 2009 Feb; 69(4):1439-47. PubMed ID: 19208842
[TBL] [Abstract][Full Text] [Related]
49. Biomarkers of Vitamin D Status and Risk of ESRD.
Rebholz CM; Grams ME; Lutsey PL; Hoofnagle AN; Misialek JR; Inker LA; Levey AS; Selvin E; Hsu CY; Kimmel PL; Vasan RS; Eckfeldt JH; Coresh J;
Am J Kidney Dis; 2016 Feb; 67(2):235-42. PubMed ID: 26475393
[TBL] [Abstract][Full Text] [Related]
50. Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study.
Schneider AL; Lutsey PL; Selvin E; Mosley TH; Sharrett AR; Carson KA; Post WS; Pankow JS; Folsom AR; Gottesman RF; Michos ED
Eur J Neurol; 2015 Aug; 22(8):1220-7. PubMed ID: 25962507
[TBL] [Abstract][Full Text] [Related]
51. Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.
Schenk JM; Till CA; Tangen CM; Goodman PJ; Song X; Torkko KC; Kristal AR; Peters U; Neuhouser ML
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1484-93. PubMed ID: 25085836
[TBL] [Abstract][Full Text] [Related]
52. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
[TBL] [Abstract][Full Text] [Related]
53. Vitamin D-binding protein levels do not influence the effect of vitamin D repletion on serum PTH and calcium: data from a randomized, controlled trial.
Ponda MP; McGee D; Breslow JL
J Clin Endocrinol Metab; 2014 Jul; 99(7):2494-9. PubMed ID: 24712573
[TBL] [Abstract][Full Text] [Related]
54. Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study.
Sawada N; Inoue M; Iwasaki M; Yamaji T; Shimazu T; Sasazuki S; Tsugane S
Eur J Clin Nutr; 2017 Jan; 71(1):132-136. PubMed ID: 27759068
[TBL] [Abstract][Full Text] [Related]
55. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland).
Ahonen MH; Tenkanen L; Teppo L; Hakama M; Tuohimaa P
Cancer Causes Control; 2000 Oct; 11(9):847-52. PubMed ID: 11075874
[TBL] [Abstract][Full Text] [Related]
56. Prediagnostic Serum Vitamin D, Vitamin D Binding Protein Isoforms, and Cancer Survival.
Weinstein SJ; Mondul AM; Layne TM; Yu K; Huang J; Stolzenberg-Solomon RZ; Ziegler RG; Purdue MP; Huang WY; Abnet CC; Freedman ND; Albanes D
JNCI Cancer Spectr; 2022 Mar; 6(2):. PubMed ID: 35603848
[TBL] [Abstract][Full Text] [Related]
57. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
[TBL] [Abstract][Full Text] [Related]
58. 25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: The ARIC study.
Michos ED; Misialek JR; Selvin E; Folsom AR; Pankow JS; Post WS; Lutsey PL
Atherosclerosis; 2015 Jul; 241(1):12-7. PubMed ID: 25941991
[TBL] [Abstract][Full Text] [Related]
59. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.
Jacobs ET; Giuliano AR; Martínez ME; Hollis BW; Reid ME; Marshall JR
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):533-7. PubMed ID: 15225833
[TBL] [Abstract][Full Text] [Related]
60. Maternal and Newborn Vitamin D-Binding Protein, Vitamin D Levels, Vitamin D Receptor Genotype, and Childhood Type 1 Diabetes.
Tapia G; Mårild K; Dahl SR; Lund-Blix NA; Viken MK; Lie BA; Njølstad PR; Joner G; Skrivarhaug T; Cohen AS; Størdal K; Stene LC
Diabetes Care; 2019 Apr; 42(4):553-559. PubMed ID: 30692241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
